Search results for "pic"

showing 10 items of 8215 documents

Giant enchondroma recurrence of the proximal phalanx of the fifth finger: A case report

2020

Enchondroma (EC) is a benign and cartilage-forming tumor that causes intramedullary lesions. Moreover, EC is the most common bone tumor in the phalanges and metacarpal bones of the hand, deforming the structure and causing pain and functional limitation. The management of this neoplasia is the surgical treatment and the approach that is well-accepted consists in the curettage followed by the void augmentation with biological or synthetic fillers. The results from surgery are usually good and the recurrence rate is low (2-15%). In this article we report a case of EC recurrence of the proximal phalanx of the fifth finger of the hand after curettage and grafting. The patient was treated with t…

medicine.medical_specialtyProximal phalanxmedicine.medical_treatment030231 tropical medicineEnchondromaCase ReportMetacarpal boneslaw.inventionIntramedullary rod03 medical and health sciences0302 clinical medicinelawmedicineEnchondroma030212 general & internal medicineSurgical treatmentbusiness.industryGeneral MedicinePhalanxmedicine.diseaseCurettageSurgeryAmputationTsuge techniqueEnchondroma hand Tsuge techniqueEnchondroma; hand; Tsuge techniquehandbusiness
researchProduct

Adverse effects of iodine thyroid blocking: a systematic review

2011

(131)I, when released in a radiological or nuclear accident as happened recently in Fukushima, Japan, may cause thyroid cancer as a long-term consequence. Iodine thyroid blocking (ITB) is known to reduce the risk of developing thyroid cancer. Potential adverse effects of ITB have not been systematically investigated so far. This article summarises the results of a review on adverse effects of ITB based on a systematic literature search in scientific medical databases. A meta-analysis was not performed as identified studies displayed major heterogeneity. The search resulted in 14 articles relevant to the topic, reporting mostly on surveys, ecological and intervention studies. Only one study …

medicine.medical_specialtyPsychological interventionMEDLINEContext (language use)Health careThyroid Diseases/chemically inducedMedicineHumansRadiology Nuclear Medicine and imagingThyroid NeoplasmsIntensive care medicineAdverse effectThyroid cancerRadiationRadiological and Ultrasound Technologybusiness.industryPotassium IodidePublic Health Environmental and Occupational HealthCase-control studyGeneral MedicinePharmacoepidemiologymedicine.diseasePotassium Iodide/adverse effectsThyroid DiseasesReview Literature as TopicCase-Control StudiesThyroid Neoplasms/drug therapybusiness
researchProduct

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017

2017

AbstractTherapeutic drug monitoring (TDM) is the quantification and interpretation of drug concentrations in blood to optimize pharmacotherapy. It considers the interindividual variability of pharmacokinetics and thus enables personalized pharmacotherapy. In psychiatry and neurology, patient populations that may particularly benefit from TDM are children and adolescents, pregnant women, elderly patients, individuals with intellectual disabilities, patients with substance abuse disorders, forensic psychiatric patients or patients with known or suspected pharmacokinetic abnormalities. Non-response at therapeutic doses, uncertain drug adherence, suboptimal tolerability, or pharmacokinetic drug…

medicine.medical_specialtyPsychopharmacologyGuidelines as Topic030226 pharmacology & pharmacy03 medical and health sciencesNeuropharmacology0302 clinical medicinePharmacotherapyHealth caremedicineHumansPharmacology (medical)PsychiatryIntensive care medicinePsychotropic Drugsmedicine.diagnostic_testbusiness.industryMental DisordersGeneral Medicinemedicine.disease3. Good healthAntiparkinson drugNeuropsychopharmacologySubstance abusePsychiatry and Mental healthTolerabilityTherapeutic drug monitoringDrug Monitoringbusiness030217 neurology & neurosurgeryPharmacogeneticsPharmacopsychiatry
researchProduct

Mechanism of New Antipsychotic Medications

2003

Antagonism of D 2 -like dopamine receptors is the putative mechanism underlying the antipsychotic efficacy of psychotropic drugs. Positron emission tomographic studies suggest that the antipsychotic effect of dopamine receptor antagonists occurs within a therapeutic window between 60% and 80%(striatal) D 2 receptor occupancy. The incidence of extrapyramidal side effects increases above the 80% threshold. However, the novel atypical antipsychotic drug, aripiprazole, occupies up to 95% of striatal D 2 -like dopamine receptors at clinical doses, and the incidence of extrapyramidal side effects with aripiprazole is no higher than with placebo. The most likely explanation for this finding is ari…

medicine.medical_specialtyPsychosismedicine.drug_classmedicine.medical_treatmentAripiprazoleAtypical antipsychoticQuinolonesPharmacologyPartial agonistPiperazinesBasal Ganglia DiseasesArts and Humanities (miscellaneous)Dopamine receptor D2Internal medicinemedicineHumansAntipsychoticDose-Response Relationship DrugReceptors Dopamine D2Putamenmedicine.diseaseCorpus StriatumProlactinDopamine D2 Receptor AntagonistsPsychiatry and Mental healthEndocrinologyMechanism of actionDopamine receptorSchizophreniaAripiprazolemedicine.symptomPsychologyAntipsychotic AgentsTomography Emission-Computedmedicine.drugArchives of General Psychiatry
researchProduct

Medications between psychiatric and addictive disorders

2016

International audience; Introduction : Many epidemiological studies have revealed a frequent co-occurrence of psychiatric and substance use disorders. The term used in the literature to refer to this co-occurrence is dual diagnosis. The high prevalence of dual diagnosis has led physicians to observe the effects of medication prescribed to treat psychiatric disorders on the co-occurring substance use disorder and vice versa. The concept of medications between psychiatric and addictive disorders stems from these clinical observations, alongside which, however, it has developed from the observation that both psychiatric and substance use disorders share common neurobiological pathways and trig…

medicine.medical_specialtyPsychotherapistSubstance-Related Disordersmedia_common.quotation_subject[SDV]Life Sciences [q-bio][ SDV.MHEP.PSM ] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthAddictionModafinilMirtazapine[ SCCO.PSYC ] Cognitive science/Psychology03 medical and health sciences0302 clinical medicineCognitionEpidemiology of child psychiatric disordersmedicineAnimalsHumansDual diagnosisMedical prescriptionPsychiatryClozapineBiological PsychiatryDepression (differential diagnoses)ComputingMilieux_MISCELLANEOUSmedia_commonPharmacologyPsychotropic DrugsDepressionAddictionmedicine.disease3. Good health030227 psychiatrySubstance abuseClinical researchSchizophreniaDiagnosis Dual (Psychiatry)[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health[SCCO.PSYC]Cognitive science/PsychologySchizophreniaDual diagnosisPsychologyPsychiatric disorders030217 neurology & neurosurgery
researchProduct

Manualized psychodynamic-interactional group therapy for the treatment of somatoform pain disorders.

2010

Medically unexplained and clinically significant symptoms of pain are highly prevalent in the general population. More than one third of all patients in general practices and various departments of hospitals suffer from somatoform disorders with pain being the main complaint of 70% of these patients. This treatment manual is the first disorder-specific, psychodynamically oriented treatment for these patients. Based on psychodynamic-interactional group psychotherapy, it focuses on disorder-specific aspects as well as on psychic and interpersonal problems which have resulted from adverse childhood experiences and insecure attachment. In three treatment phases comprising an “information and mo…

medicine.medical_specialtyPsychotherapistmedicine.medical_treatmentTransfer PsychologyPopulationPsychological interventionMEDLINEPainGroup psychotherapyLife Change EventsMind-Body Relations MetaphysicalInterpersonal relationshipManuals as TopicPatient Education as TopicmedicineHumansPain ManagementAffective SymptomsAdverse Childhood ExperienceseducationPsychiatrySomatoform Disorderseducation.field_of_studyCommunicationPsychodynamicsSocial relationPsychoanalytic TherapyPsychiatry and Mental healthClinical PsychologyTreatment OutcomeChronic DiseasePsychotherapy GroupPshychiatric Mental HealthPsychologyArousalBulletin of the Menninger Clinic
researchProduct

A common role for psychotropic medications: memory impairment.

2002

Summary The psychopathologic profile of mental disorders is very diverse and psychotropic medications used to treat them differ in their chemical structure. Nevertheless, these drugs share these four characteristics: delayed onset of clinical response, not one of them can be said to cure, there is a high number of non-responders, and the mechanism responsible for their therapeutic action is not known. It is hypothesized that the action of psychotropic medications is memory impairment, understanding memory as the trace left in the nervous system not only by individual experiences but also by genetic and epigenetic phenomena. It is suggested that it would be beneficial to translate some resea…

medicine.medical_specialtyPsychotropic DrugsTherapeutic actionMechanism (biology)Mental DisordersDelayed onsetBrainGeneral MedicineModels PsychologicalAntidepressive AgentsAction (philosophy)Research strategiesMemorymedicineCyclic AMPMemory impairmentHumansPsychologyPsychiatryClinical psychologyAntipsychotic AgentsSignal TransductionMedical hypotheses
researchProduct

Bibliometric analysis of leishmaniasis research in Medline (1945-2010)

2012

Background Publications are often used as a measure of success of research work. Leishmaniasis is considered endemic in 98 countries, most of which are developing. This article describes a bibliometric review of the literature on leishmaniasis research indexed in PubMed during a 66-year period. Methods Medline was used via the PubMed online service of the US National Library of Medicine. The search strategy was Leishmania [MeSH] or leishmaniasis [MeSH] from 1 January 1945 until 31 December 2010. Neither language nor document type restrictions were employed. Results A total of 20,780 references were retrieved. The number of publications increased steadily over time, with 3,380 publications f…

medicine.medical_specialtyPubMedBibliometric analysisAsiaBiomedical ResearchDiffuse cutaneous leishmaniasisMEDLINEOceaniaBibliometryMEDLINEBibliometricsLeishmaniasis cutaneousDiffuse cutaneous LeishmaniasismedicineAnimalsHumansLeishmaniasis visceralLeishmaniasisLeishmaniasis mucocutaneousPublishingLeishmaniaTraditional medicinebusiness.industryResearchScientific productionLeishmaniasismedicine.diseaseUnited StatesEuropeLatin AmericaInfectious DiseasesMappingBibliometricsFamily medicineAfricaNorth AmericaParasitologyPeriodicals as TopicbusinessScientific productionBrazilParasites & Vectors
researchProduct

Iron Chelation Therapy in thalassaemia major: a sistematic review with meta-analyses of 1520 patients included on randomized clinical trials

2011

The effectiveness of deferoxamine (DFO), deferiprone (DFP), or deferasirox (DFX) in thalassemia major was assessed. Outcomes were reported as means±SD, mean differences with 95% CI, or standardized mean differences. Statistical heterogeneity was tested using χ2 (Q) and I2. Sources of bias and Grading of Recommendations Assessment, Development and Evaluation system (GRADE) were considered. Overall, 1520 patients were included. Only 7.4% of trials were free of bias. Overall measurements suggest low trial quality (GRADE). The meta-analysis suggests lower final liver iron concentrations during associated versus monotherapy treatment (p<0.0001), increases in serum ferritin levels during DFX 5, 1…

medicine.medical_specialtyPyridonesIronMEDLINEThalassemiaSiderophoresDeferoxamineIron Chelating AgentsChelation treatment thalassaemia clinical trials iron overload meta-analysisBenzoatesGastroenterologylaw.inventionchemistry.chemical_compoundRandomized controlled triallawInternal medicinemedicineHumansVentricular FunctionDeferiproneMolecular BiologyRandomized Controlled Trials as TopicEjection fractionbusiness.industryMyocardiumbeta-ThalassemiaDeferasiroxBeta thalassemiaCell BiologyHematologyTriazolesmedicine.diseaseChelation TherapySurgeryDeferoxamineDeferasiroxTreatment OutcomeLiverchemistryMeta-analysisFerritinsMolecular MedicineDrug Therapy CombinationbusinessDeferipronemedicine.drug
researchProduct

Quality assurance in the treatment of colorectal cancer: the EURECCA initiative

2014

Colorectal cancer is one of the most common cancers in Europe. Over the past few decades, important advances have been made in screening, staging and treatment of colorectal cancer. However, considerable variation between and within European countries remains, which implies that further improvements are possible. The most important remaining question now is: when are we, health care professionals, delivering the best available care to patients with colon or rectal cancer? Currently, quality assurance is a major issue in colorectal cancer care and quality assurance awareness is developing in almost all disciplines involved in the treatment of colorectal cancer patients. Quality assurance has…

medicine.medical_specialtyQuality managementQuality Assurance Health CareColorectal cancercolorectal cancerauditAuditquality assurancemultidisciplinarityFeedbackHealth caremedicineHumansguidelinesIntensive care medicineQuality of Health CareSettore MED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIAClinical Trials as TopicClinical Auditbusiness.industryCancerHematologyGuidelinemedicine.diseaseSurgeryEuropeClinical trialOncologyData Interpretation StatisticalPractice Guidelines as TopicColorectal NeoplasmsbusinessQuality assurance
researchProduct